Inotiv

hApoE4 knockin rats

HsdSage:SD-ApoE4em1(hApoE4)Sage
Location
Order Today
+1 800 793 7287 Online order  

Order code: 359

Description
Health monitoring reports
Pricing
Technical resources

  • Background strain: Sprague Dawley
  • Homozygous replacement of the Rat ApoE gene with the Human ApoE4 gene

Availability: Live colony
Zygosity genotype: Homozygous

Apolipoprotein E (ApoE) is a critical apoprotein of the chylomicron which binds to a specific receptor on liver cells and peripheral cells. Additionally, the 4 allele of ApoE (ApoE4) is a major risk factor for Alzheimer's disease (AD), with possession of at least one ApoE4 allele in 40-65% of patients with AD and a patient with 2 ApoE4 alleles having up to 20 times the risk of developing AD.

ApoE4 has been implicated in Alzheimer's disease and cognition, making this a useful model for the study of atherosclerosis, Alzheimer's and nerve injury.


Origin:

The hApoE4 KI rat model was originally created at SAGE Labs, Inc. in St. Louis, MO and distributed out of the Boyertown, PA facility. The line continues to be maintained through the original SAGE Labs animal inventory acquired by Envigo, then Envigo was acquired by Inotiv in 2021.

Diet and Husbandry:
Our rodent models are raised and maintained on Teklad diet, bedding, and enrichment products:

Model Support Services:
Inotiv offers related model support services to deliver research-ready models to your facility:

Available regions:

For pricing information, please contact us using the phone number above.

Research use and related publications

2025 Product guide

Receive a copy of our current research models and services product guide.

Download today  
SCIENCE Surgeon - clinical

SCIENTIFIC

INSIGHTS

Keep up-to-date with the latest industry thinking and scientific insights

Explore today
90-anni-globe-widget

More than 90 years of working together, to build a healthier and safer world

Explore our history
Decoration

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
Subscribe now